Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...

Keytruda (pembrolizumab) plus Lenvima (lenvatinib) and chemotherapy improved progression-free survival but did not achieve ...

Extended collaboration will further explore the capabilities of Medidata Platform from early-phase trials to post-marketing ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights how artificial intelligence, real-time ...

Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...

End-to-end offering is designed to streamline site activation and optimize visibility in critical research processes.

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights increased data management, DE&I, and ...

“The goal is to develop life-saving medications for patients faster. That comes down to saving time and money,” said Bonne ...

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, discusses challenges such as high costs and long ...

Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...

Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...

Initiatives to Establish Capabilities in Early Phase Clinical Research in Malaysia ...